Skip to main content Accessibility help
×
Home
Hostname: page-component-544b6db54f-5rlvm Total loading time: 2.311 Render date: 2021-10-16T18:24:47.957Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Lacosamide

Published online by Cambridge University Press:  01 June 2018

Philip N. Patsalos
Affiliation:
UCL Institute for Neurology
Erik K. St Louis
Affiliation:
Mayo Clinic
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Baulac, M, Rosenow, F, Toledo, M, Terada, K, Li, T, De Backer, M, Werhahn, KJ, Brock, M. Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial. Lancet Neurology 2017; 16: 4354.CrossRefGoogle ScholarPubMed
Ben-Menachem, E, Biton, V, Jatuzis, D, Abdul-Khalil, B, Doty, P, Rudd, GD. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 2007; 48: 13081317.CrossRefGoogle ScholarPubMed
Beyreuther, BK, Freitag, J, Heers, C, Krebsfanger, N, Scharfenecker, U, Stohr, T. Lacosamide: a review of preclinical properties. CNS Drug Reviews 2007; 13: 2142.CrossRefGoogle ScholarPubMed
Biton, V, Rosenfeld, WE, Whitesides, J, Fountain, NB, Vaiciene, N, Rudd, GD. Intravenous lacosamide as replacement of oral lacosamide in patients with partial-onset seizures. Epilepsia 2008; 49: 418424.CrossRefGoogle ScholarPubMed
Halasz, P, Kalviainen, R, Mazurkiewicz-Beldzinska, M, Rosenow, F, Doty, P, Hebert, D, Sullivan, T, on behalf of the SP755 Study Group. Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled study. Epilepsia 2009; 50: 443453.CrossRefGoogle Scholar
Höfler, J, Trinka, E. Lacosamide as a new treatment option in status epilepticus. Epilepsia 2013; 53: 393404.CrossRefGoogle Scholar
Kellinghaus, C, Berning, S, Besselmann, M. Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy. Epilepsy and Behavior 2009; 14: 429431.CrossRefGoogle ScholarPubMed
Miro, J, Toledo, M, Santamarina, E, Ricciardi, AC, Villanueva, V, Pato, A, Ruiz, J, Juvany, R, Falip, M. Efficacy of intravenous lacosamide as add-on treatment in refractory status epilepticus: a multicentric prospective study. Seizure 2013; 22: 7779.CrossRefGoogle ScholarPubMed
Novy, J, Pastsalos, PN, Sander, JW, Sisodiya, SM. Lacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: a pharmacodynamic interaction? Epilepsy and Behavior 2011; 20: 2023.CrossRefGoogle ScholarPubMed
Nunes, VD, Sawer, L, Neilson, J, Sarri, G, Cross, JH. Profile of lacosamide and its long-term treatment of epilepsy: a prospective from the updated NICE guidelines. Neuropsychiatric Disease and Treatment 2013; 9: 467476.CrossRefGoogle Scholar
Patsalos, PN, Berry, DJ. Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate. Expert Opinion in Pharmacotherapy 2012; 13: 699715.CrossRefGoogle ScholarPubMed
Verrotti, A, Loiacono, G, Pizzolorusso, A, Parisi, P, Bruni, O, Luchetti, A, Zamponi, N, Cappanera, S, Grosso, S, Kluger, G, Janello, C, Franzoni, E, Elia, M, Spalice, A, Coppola, G, Striano, P, Pavone, P, Savasta, S, Viri, M, Romeo, A, Aloisi, P, Gobbi, G, Ferretti, A, Cusmai, R, Curatolo, P. Lacosamide in paediatric and adult patients: comparison of efficacy and safety. Seizure 2013; 22: 210216.CrossRefGoogle Scholar
Vossler, DG, Wechsler, RT, Williams, P, Byrnes, W, Therriault, S; ALEX-MT study group. Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: results from a multicenter, open-label trial. Epilepsia 2016; 57: 16251633.CrossRefGoogle ScholarPubMed
Wechsler, RT, Li, G, French, J, O’Brien, TJ, D’Cruz, O, Williams, P, Goodson, R, Brock, M; ALEX-MT Study Group. Conversion to lacosamide monotherapy in the treatment of focal epilepsy: results from a historical-controlled, multicenter, double-blind study. Epilepsia 2014; 55: 10881098.CrossRefGoogle ScholarPubMed

Send book to Kindle

To send this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Send book to Dropbox

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Dropbox.

Available formats
×

Send book to Google Drive

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Google Drive.

Available formats
×